Radiopharma

Radiopharma news

Radiopharmaceutical approvals, deals, isotope supply, manufacturing and trials. Sources on every story.

RadiopharmaOct 15, 2026

Telix to Present 20 Abstracts at EANM Conference

Telix Pharmaceuticals will showcase clinical data across prostate, brain, and renal cancer programs, plus next-generation theranostics platforms, at the nuclear medicine meeting.

Telix PharmaceuticalsEANMtheranostics

RadiopharmaOct 15, 2026

BMS' Actinium-225 Drug Meets Phase III Endpoint in NETs

Bristol Myers Squibb's RYZ101 met its primary PFS endpoint in GEP-NETs after lutetium-177 failure, marking a landmark result for alpha-emitting radiopharmaceuticals.

actinium-225radiopharmaceuticalsneuroendocrine tumors